Adalimumab (Humira) (Human)

Product Description

Adalimumab (Humira) is a recombinant human IgG1 monoclonal antibody specific for Tumor Necrosis Factor-Alpha (TNF-) and is used to treat rheumatic arthritis, intestinal disorders, dermatological diseases and cancer. Adalimumab specifically binds to TNF alpha and blocks its interaction with p55 and p75 cell surface TNF receptors and reduces the inflammation and subsequently improves the patients health. Drug level quantification can be important to adapt patient prescription or to switch to an alternative TNF inhibitor drug. EMA Bio-analytical Method Validation Guidelines and industry-recommended practices for ligand-binding assays were used for validation of this kit. This Adalimumab ELISA kit has been developed for specific quantification of Adalimumab concentration in human serum or plasma with high sensitivity and reproducibility. BioVisions Adalimumab ELISA kit is a sandwich ELISA assay for the quantitative measurement of Adalimumab in human serum, plasma. The density of color is proportional to the amount of human Adalimumab captured from the samples.